Gifford Bioscience is currently operational, prioritising COVID-19 work on the SARS-CoV2 spike protein : ACE2 interaction, using both SPR Biacore and radiometric techniques. The studies are with recombinant protein, live cells and human lung and brain tissue.

Copyright © 2008 – 2020 Gifford Bioscience Limited
Privacy Policy